Executive Director, Regulatory Affairs CMC AllakosExecutive Director, Regulatory Affairs CMCRedwood City, CaliforniaLeads the development of strategic CMC plans and tactical implementation for the creation and submission of Regulatory documents, e.g., INDs, BLAs, CTAs, MAAs, and other relevant regulatory filings. Exec Director Regulatory Affairs/CMC Allakos Inc. is a dynamic clinical-stage biopharmaceutical company developing first-in-class antibody-based therapeutics to treat allergic and inflammatory diseases.
Executive Director Housing Authority Of The County Of MarinExecutive DirectorSan Rafael, CaliforniaUnder policy direction of the Board of Commissioners, plans, organizes and provides administrative direction, oversight and coordination for all Housing Authority functions and activities; provides policy guidance and program evaluation to the Board of Commissioners and management staff; encourages and facilitates provision of services to agency tenants, home buyers, developers and other clients and members of the public; oversees the management of all agency assets; fosters cooperative working relationships with inter-governmental, regulatory, non-profit, business and various public and private groups; pursues appropriate avenues of funding and service development; and performs related work as required. Equivalent to graduation from a four-year college or university with major course work in business or public administration, public policy, community or urban development, architecture, engineering, or a field related to the work and seven years of management experience in the planning, development, construction, rehabilitation, and/or management of a variety of housing alternatives.
Executive Director of Sales TMR OperationsExecutive Director of SalesNapa, California$175,000–$210,000 / yearThrough strategic leadership, innovative sales strategies, and alignment across Food & Beverage, Event Services, and external partnerships, elevate The Meritage Resort and Spa’s position as Napa’s premier destination for meetings, leisure, and lifestyle experiences. Oversee all property-based sales teams—including Catering, EMM, Destination, In-Market, and Leisure Sales—fostering collaboration and performance excellence in partnership with Marketing, Revenue Management, and Events/Conference Services.
Executive Director, GxP Quality and Compliance Revolution MedicinesExecutive Director, GxP Quality and ComplianceRedwood City, CaliforniaThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. 15+ years of progressive experience in GxP Quality and Compliance within the pharmaceutical, biotechnology, medical device, or related life sciences industry with extensive knowledge of FDA regulations, ICH Guidelines, EU GMP, and global GxP requirements.
Executive Director of Campus Operations - Administration and Finance Cal PolyExecutive Director of Campus Operations - Administration and FinanceVallejo, CaliforniaThe Administration and Finance Division plays a vital role in supporting the university’s operational backbone, encompassing areas such as finance, budgeting, facilities, public safety, environmental health and safety, procurement, University Housing, Information Technology Services, Performing Arts Center, Cal Poly Partners, and divisional operations. The SVP of Administration and Finance reports directly to the University President and serves as a member of the President’s Cabinet, working collaboratively with other university divisions to advance strategic initiatives, ensure financial sustainability, and maintain a safe, inclusive, and well-functioning campus environment.
Executive Director, Computational Systems Biology Revolution MedicinesExecutive Director, Computational Systems BiologyRedwood City, CaliforniaThe individual will lead a team of computational biologists and bioinformaticians focused on acquisition, organization, and analysis of large multi-omics data sets, using both public and proprietary data sources, that will help inform treatment strategies and guide patient stratification for a growing pipeline of RAS(ON) and targeted oncology therapeutics. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
Executive Director, Clinical Supply Chain Revolution MedicinesExecutive Director, Clinical Supply ChainRedwood City, CaliforniaThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Executive Director, Early Clinical Development Revolution MedicinesExecutive Director, Early Clinical DevelopmentRedwood City, CaliforniaHas demonstrated collaborate behaviors on enterprise-level strategic initiatives with a variety of internal and external partners and stakeholders - including clinical investigators/clinicians, scientists and key opinion leaders (KOLs), as well as internal groups, including other groups in development, research, business development, commercial, legal, etc. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
Executive Director, Clinical Development Revolution MedicinesExecutive Director, Clinical DevelopmentRedwood City, CaliforniaHas demonstrated collaborate behaviors on enterprise-level strategic initiatives with a variety of internal and external partners and stakeholders - including clinical investigators/clinicians, scientists and key opinion leaders (KOLs), as well as internal groups, including other groups in development, research, business development, commercial, legal, etc. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
Executive Director, Global Patient Safety Quality and Compliance - Pharmacovigilance Revolution MedicinesExecutive Director, Global Patient Safety Quality and Compliance - PharmacovigilanceRedwood City, CaliforniaThe responsibilities of this role include oversight of the PV-QMS, PV training strategy, PV controlled documentation, inspection and audit management, ensuring inspection readiness, Corrective Action Preventive Action (CAPA) management, Quality Assurance (QA), and maintenance of Good Clinical Practice (GCP), and Good Pharmacovigilance Practices (GVP) in partnership with GPS management, QA, and staff. This critical role will require strategic thinking, expert knowledge of global PV regulations (i.e. GCP, GVP), the ability to influence and communicate ideas effectively, results orientation, collaboration with cross-functional teams, technical expertise, and vendor management skills to ensure compliance with regulatory requirements to safeguard patient well-being.
Executive Director / Vice President, Biology & Translational Pharmacology ProfluentExecutive Director / Vice President, Biology & Translational PharmacologyEmeryville, CAProvide accountable leadership for cross-functional therapeutic program teams, integrating translational biology, genome editing, protein engineering, delivery, pharmacology, bioanalytics, CMC, regulatory, and preclinical development expertise. Outstanding written and verbal communication skills, with the ability to tailor scientific and strategic messages for audiences ranging from technical project teams to senior executives, board members, external advisors, partners, and generalist investors.
Senior/Executive Director, Business Operations BridgeBio Pharma, Inc.Senior/Executive Director, Business OperationsSan Francisco, CA$249,000–$330,000 / year2-5 years of professional experience in management consulting (life sciences preferred), post-Series A investing, investment banking, venture capital, equity research, and/or corporate role in a therapeutics company. The final salary offered to a successful candidate will depend on several factors that may include but are not limited to the type and length of experience within the job, type, and length of experience within the industry, educational background, location of residence and performance during the interview process.
Executive Director, Biostatistics Exelixis Inc.Executive Director, BiostatisticsAlameda, CA$271,000–$385,000 / yearEDUCATION/EXPERIENCE/KNOWLEDGE & SKILLS: Education/Experience: MS/MA degree in Statistics/Biostatistics or related discipline and a minimum of 16 years of related experience; or, PhD in Statistics/Biostatistics or related discipline and a minimum of 15 years of related experience; or, Equivalent combination of education and relevant experience in oncology. SUMMARY/JOB PURPOSE: Leads the biostatistics function in developing statistical strategy, design, and analyses for conducting clinical trials in all phases for multiple compounds.
Executive Director, Global Commercial Lead Revolution Medicines, Inc.Executive Director, Global Commercial LeadRedwood City, CA$252,000–$315,000 / yearThe Opportunity: Reporting to the VP, Global Commercial Development Disease Area Lead, this newly created role will serve as a leader for continuing to build our global oncology marketing capabilities driving global commercial strategy at product team and overseeing global launch strategy and lifecycle planning for a given indication/indications. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
Affordable Housing Finance Product Manager - Executive Director Morgan StanleyAffordable Housing Finance Product Manager - Executive DirectorSan Francisco, CA$150,000–$250,000 / yearThis individual will serve as a senior product owner and relationship manager for affordable housing private equity strategies, working closely with internal stakeholders, fund managers, sponsors, legal counsel, risk partners, and other control functions to ensure disciplined execution, strong portfolio performance, and alignment with Morgan Stanley's community development, risk management, and business objectives. Lead sourcing and originations for new affordable housing private equity investment opportunities, including evaluation of fund managers, sponsors, markets, investment structures, projected returns, community development impact, and strategic fit.
NewExecutive Director, Responsible Investment Strategy Specialist - West Coast Morgan StanleyExecutive Director, Responsible Investment Strategy Specialist - West CoastSan Francisco, CaliforniaOur values - putting clients first, doing the right thing, leading with exceptional ideas, committing to diversity and inclusion, and giving back - aren’t just beliefs, they guide the decisions we make every day to do what's best for our clients, communities and more than 80,000 employees in 1,200 offices across 42 countries. The role provides end-to-end leadership for assigned product categories, serves as a key liaison to designated investment teams, and acts as a product champion accountable for positioning, content strategy, and ongoing communication and training across all distribution channels.
Executive Director, Global Commercial Lead Revolution MedicinesExecutive Director, Global Commercial LeadRedwood City, CaliforniaReporting to the VP, Global Commercial Development Disease Area Lead, this newly created role will serve as a leader for continuing to build our global oncology marketing capabilities driving global commercial strategy at product team and overseeing global launch strategy and lifecycle planning for a given indication/indications. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
Executive Director, Patents Revolution MedicinesExecutive Director, PatentsRedwood City, California$315,000–$362,000 / yearThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. The role will function as a key strategic partner to the VP and a trusted advisor to senior leadership, with a primary focus on strengthening the durability and value of company assets worldwide, anticipating competitive threats, and identifying and mitigating vulnerabilities.
Business Relationship Manager Area Manager - Executive Director JPMorgan Chase & CoBusiness Relationship Manager Area Manager - Executive DirectorSan Francisco, CABuild collaborative relationships with partners across lines of business - Chase Wealth Management, Home Lending, Branch Teams, Commercial Bank, and Private Bank - to foster a One Chase, client-centric environment and represent the bank in a community leadership capacity such as Chamber of Commerce and local non-profit boards. Coach and develop team on all aspects of managing a portfolio, including relationship management, prospecting, profitability, client experience, and risk management; provide expertise to team on loan structuring, pricing, and developing customized solutions; help team identify solutions to complex challenges.
Director Of Communications And Executive Affairs KIPP Bay Area Schools - San FranciscoDirector Of Communications And Executive AffairsOakland, CA$130,000–$151,000 / yearThis role also oversees best-in-class board governance systems, structures and processes; CEO communications, visibility, and support; key systems that support a strong Regional Support Office (RSO) culture; and systems to ensure excellent communication and coordination around our 2030 vision and goals, and how those translate to annual initiatives and key results. Develop and steward KIPP NorCal's organizational narrative, brand, and communications strategy across internal and external audiences, ensuring KIPP NorCal speaks with a consistent, high-impact voice across every audience and channel.